Significant hyperglycemia was observed in both fasting and fed states compared to control starting at 10 days and enduring until 28 days post-injection in wildtype mice treated with siPrkar1a sequences in a manner correlating with the potency of Prkar1a reduction (Fig 2B and 2C). This evidence concerns the gene PRKAR1A and Hyperglycemia.